»
Antikörper
»
anti-Mitogen-Activated Protein Kinase Kinase 1/2 (MAP2K1/2) (pSer218,pSer222) Anti...
Mitogen-Activated Protein Kinase Kinase 1/2 (MAP2K1/2) (pSer218,pSer222) Antikörper
| Antigen |
|
|
Epitope
|
|
| Klonalität |
Polyklonal |
|
Wirt
|
|
|
Reaktivität
|
|
|
Applikation
|
|
| Produktnummer |
ABIN238350 |
| Menge |
0.05 mg (1.0 mg/ml) |
| Preis |
170,00 € Zzgl. Versandkosten €20,00 und MWSt
|
| Lieferung nach |
|
| Verfügbarkeit |
Lieferung in 7 bis 10 Werktagen |
|
Produktmerkmale
|
Synonyms: MEK1, MEK2, MKK2, MKK1, PRKMK1, PRKMK2
|
|
Weitere Bezeichnung
|
MAPKK1 / MAPKK 2
|
|
Immunogen
|
Synthetic peptide (coupled with KLH) derived from aminoacid sequence 33-53 of humanMAPK Kinase 1. Remarks: The immunogen sequence is highly conserved within species (human, mouse,rat, hamster, bovine etc. ).
|
|
Kreuzreaktivität
|
Human
|
|
Beschreibung
|
MEK (MAPKK, kinase of mitogen-activated protein kinase) is the medium one of threecomponents of MAP kinase cascade - an important signaling pathway that regulates cellgrowth and differentiation. Raf (MAPKKK) activates MEK 1 and 2 via phosphorylation of twoserine residues (Ser218 and Ser222). Activated MEK 1/2 then acts as a dual specificitykinase phosphorylating both a threonine and a tyrosine residue on ERK (MAPK,mitogen-activated protein kinase). This phosphorylation of ERK by MEK 1/2 is a critical stepin the MAP kinase cascade. Phosphorylated ERK is capable of translocating to the nucleus,where it regulates gene expression by activating transcription factors.
|
|
Spezifität
|
The polyclonal antibody reacts with MEK 1/2. MEK 1 and MEK 2 are integral components ofthe MAP kinase cascade, an important pathway for cell growth and differentiation. Species: Human. Others not tested.
|
|
Applikationshinweise
|
Western Blotting under reducing and non-reducing conditions: Recommended dilution: 0.5 μg/mlPositive material: RAJI human Burkitt lymphoma cell lineSample preparation: Resuspend approx.50 mil. cells in 1 ml cold Lysis buffer (1%laurylmaltoside in 20 mM Tris/Cl, 100 mM NaCl pH 8.2, 50 mM NaF including Proteaseinhibitor Cocktail). Incubate 60 min on ice. Centrifuge to remove cell debris. Mix lysatewith non-reducing/reducing Laemmli SDS-PAGE sample buffer. Boil for 5 min. Reducing conditions are recommended. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
|
|
Konzentration
|
1.0 mg/ml
|
|
Reinigung
|
Purified
|
|
Buffer
|
PBS containing 15 mM sodium azide as preservative and 0.2% (w/v)high-grade BSA (Protease free) as stabilizer.
|
|
Lagerung
|
Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch
|
|
Beschränkungen
|
Nur für Forschungszwecke einsetzbar
|
Alternativen zu Antigen "Mitogen-Activated Protein Kinase Kinase 1/2 (MAP2K1/2)", Typ "Antikörper" finden
|
Wirte
|
Kaninchen (20), Maus (1)
|
|
Reaktivitäten
|
Human (21), Ratte (Rattus) (17), Maus (15), Hund (1), Säugetiere (1), Xenopus laevis (1)
|
|
Applikationen
|
Western Blot (WB) (19), Immunhistochemie (Paraffinschnitte) (IHC (p)) (6), Immunhistochemie (IHC) (4), ELISA (3), Enzyme Immunoassay (EIA) (2), Immunfluoreszenz (IF) (2)
|
|
Epitope
|
pSer217/221 (2), Ab-221 (1), pSer217 (1), pSer218/222 (1), pSer221 (1)
|